Utility of PSA in extracellular vesicles as a follow-up biomarker in prostate cancer
T-PSA ev/srm ratio could be useful for detecting tumor progression and relapses in advanced PCa. However, its utility as a follow-up biomarker for assessing clinical response to hormonal treatments and chemotherapy would be limited.
Authors
- Amaia Sandúa (ORCID: https://orcid.org/0000-0001-9012-811X)
- José Luis Perez‐Gracia (ORCID: https://orcid.org/0000-0003-4941-9075)
- Estíbaliz Alegre (ORCID: https://orcid.org/0000-0002-9053-3606)
- Álvaro González (ORCID: https://orcid.org/0000-0001-7219-2142)
Institutions
- Navarre Institute of Health Research (ES)
- Clinica Universidad de Navarra (ES)
- Universidad de Navarra (ES)
Publication Details
- Journal
- Advances in Laboratory Medicine / Avances en Medicina de Laboratorio
- Published
- 2025-07-16
- DOI
- https://doi.org/10.1515/almed-2025-0023
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fundación José Luis Castaño